50%: However, there are numerous features about an individual lymphoma that point to worse or better survival for that individual. And survival is dependent on treatment as well; the use of the monoclonal antibody, rituximab, greatly impacts on survival. Finally, the medical community does not equate survival with cure, so we tend to talk about five year survival and ten year survival.
Answered 11/1/2017
5.7k views
A doctor has provided 1 answer
A doctor has provided 1 answer
A doctor has provided 1 answer
A doctor has provided 1 answer
90,000 U.S. doctors in 147 specialties are here to answer your questions or offer you advice, prescriptions, and more.
Ask your question